Interventional Study to Improve Medication Adherence Using Patient Decision Aid
NCT06205303 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 236
Last updated 2026-04-20
Summary
Background:
Although hypothyroidism is easily treated with levothyroxine (LT4) replacement, results from several studies indicate that people receiving LT4 replacement often have under- or over-replaced thyroid function. Poor medication adherence and factors interfering with thyroxine absorption and bioavailability may result in such under-replacement. Using the COM-B (Capability, Motivation, and Opportunity - Behavior) model, a health education intervention using patient decision aid (PDA), was developed for primary care physicians to educate individuals about thyroxine replacement. Besides imparting health literacy, PDAs provide greater comfort of the patients to participate in decision making. Intervention with the PDA aims to improve the medication adherence by increasing patients' knowledge about thyroxine replacement.
Specific aims: The primary aim is to determine effectiveness of PDA in improving the knowledge, medication adherence and quality of life of the under-replaced hypothyroid adults in a primary care setting. Secondary aims are to explore their understanding and acceptance on the PDA and to assess their perceived usability of this PDA.
Methodology: A randomised controlled trial will be conducted at SingHealth Polyclinics (SHP) using mixed-method study design to determine effectiveness of PDA. Patient participants will be randomly allocated in a 1:1 ratio to either the intervention or control group. A total of 236 (118 in each group) patient participants will be enrolled by simple randomization. Eligible patient must be of age ≥21 years years and have LT4 under-replacement with Thyroid stimulating hormone (TSH) \>3.7 mIU/L within the last 6 months.
Relevance/significance of the study: Findings from the study may add evidence to the scientific knowledge of using PDA to improve medication adherence and recommend development of similar interventions for other chronic medical conditions.
Conditions
Interventions
- OTHER
-
Patient Decision Aid (Video)
Patient decision aid on thyroxine replacement is a video designed to assist the hypothyroid adults with under-replacement. It provides clear and balanced information about hypothyroidism, the role of thyroxine, treatment benefits, potential risks, and factors interfering thyroxine absorption and bioavailability. The PDA aims to empower patients to engage in shared decision-making with their healthcare provider, ensuring they understand the options and can make choices aligned with their preferences and values.
Sponsors & Collaborators
-
SingHealth Polyclinics
lead OTHER
Principal Investigators
-
Kalaipriya Gunasekaran, MD · SingHealth Polyclinics
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-15
- Primary Completion
- 2025-10-06
- Completion
- 2025-10-06
Countries
- Singapore
Study Locations
More Related Trials
-
Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
NCT01739972 ·Status: UNKNOWN ·Phase: NA
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
NCT03096613 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism
NCT05823012 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism
NCT01660126 ·Status: COMPLETED ·Phase: PHASE4
-
LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.
NCT05682482 ·Status: RECRUITING ·Phase: PHASE3
-
Neurocognitive and Metabolic Effects of Mild Hypothyroidism
NCT00565864 ·Status: COMPLETED ·Phase: PHASE4
-
Thyroid Treatment Trial
NCT00348413 ·Status: COMPLETED ·Phase: NA
-
A Study of T3 Therapy in Patients With Hypothyroidism
NCT01800617 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI)
NCT02512978 ·Status: UNKNOWN ·Phase: PHASE4
-
Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 50 μg/ 75 μg Tablets
NCT01465633 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Sustained-Release Liothyronine Sodium (T3) in Healthy Subjects
NCT01581463 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Levothyroxine on Serum Adiponectin, Insulin Resistance and Cardiovascular Risk in Patients With Hypothyroidism
NCT02467244 ·Status: COMPLETED
-
Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition
NCT02891668 ·Status: COMPLETED
-
Hypothyroidism, Metabolism and Food Intake
NCT02993562 ·Status: COMPLETED
-
The TRUST Study - CardioVascular Imaging IMT
NCT02832934 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation
NCT01916304 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Evening Versus Morning Levothyroxine Intake in Elderly
NCT03614988 ·Status: UNKNOWN ·Phase: NA
-
Dosing of LT4 in Older Individuals
NCT06073665 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
NCT01848171 ·Status: UNKNOWN ·Phase: PHASE4
-
REduction of LEvothyroxine in Adults; a SElf Controlled Study
NCT05821881 ·Status: UNKNOWN
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)
NCT03606824 ·Status: UNKNOWN ·Phase: NA
-
Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism
NCT04288115 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
NCT01801033 ·Status: WITHDRAWN
-
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
NCT06345339 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Novel Approaches to the Treatment of Hypothyroidism
NCT06731764 ·Status: RECRUITING ·Phase: PHASE2/PHASE3